Asthma Trials in Cincinnati, United States
Conditions / Asthma / Cincinnati, United States
Asthma has been the subject of sustained clinical investigation across multiple research sites.
196 total trials for this combination
Showing top 10 of 196 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01462344 | 6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old | COMPLETED | PHASE4 |
| NCT02414854 | Evaluation of Dupilumab in Patients With Persistent Asthma (Liberty Asthma Quest) | COMPLETED | PHASE3 |
| NCT04718389 | A Study of GSK3511294 (Depemokimab) Compared With Mepolizumab or Benralizumab in Participants With Severe Asthma With an Eosinophilic Phenotype | COMPLETED | PHASE3 |
| NCT02134028 | Long-Term Safety Evaluation of Dupilumab in Patients With Asthma (LIBERTY ASTHMA TRAVERSE) | COMPLETED | PHASE3 |
| NCT02258542 | A Safety Extension Study to Evaluate the Safety and Tolerability of Benralizumab (MEDI-563) in Asthmatic Adults and Adolescents on Inhaled Corticosteroid Plus LABA | COMPLETED | PHASE3 |
| NCT03170271 | A Study of the Safety and Effectiveness of Benralizumab to Treat Patients With Severe Uncontrolled Asthma. | COMPLETED | PHASE3 |
| NCT01475721 | SAS115359: A 6-month Study to Assess the Safety and Benefit of Inhaled Fluticasone Propionate/Salmeterol Combination Compared With Inhaled Fluticasone Propionate in the Treatment of Adolescents and Adults (12 Years of Age and Older) With Asthma. | COMPLETED | PHASE4 |
| NCT02760329 | Observational Study of Obstructive Lung Disease (NOVELTY) | COMPLETED | — |
| NCT00862641 | A Study of the Safety and Tolerance of Regadenoson in Subjects With Asthma or Chronic Obstructive Pulmonary Disease | COMPLETED | PHASE4 |
| NCT03213184 | Children's Respiratory and Environmental Workgroup | COMPLETED | — |